Lucila Kerbauy: Precision Medicine in AML and CAR Cells
Lucila Kerbauy, Head of Cell Therapy Center at Einstein Hospital Israelita, reposted from Larissa Zanetti, on LinkedIn:
“I’m very happy and proud to share another publication from our group on CAR-T cell therapy for acute myeloid leukemia (AML).
A special thank you to our team and collaborators who make this work possible. Advancing innovative and accessible cell therapies in Brazil and beyond is truly a collective effort.”
Quoting Larissa Zanetti’s post:
“It’s out!
I’m very proud to share our recent publication, “Precision Medicine in AML and CAR Cells: Where Are We?” — a collaborative effort uniting two leading research groups from our institution.
In this work, we explore how precision medicine and CAR-based cellular therapies (CAR-T and CAR-NK) are converging to transform the landscape of acute myeloid leukemia (AML) treatment. The review highlights the critical role of patient-specific approaches, novel target discovery, and next-generation cell engineering in shaping the future of personalized immunotherapy.
I truly believe that as the field of advanced cell therapies continues to expand, the integration of precision medicine principles will become increasingly essential.
A huge thank you to my incredible collaborators and mentors who made this work possible.”
Article: Precision medicine with car cells in acute myeloid leukemia: where are we?
Authors: Larissa C. Zanetti, Victoria Tomaz, Ingrid Ferreira de Souza, Paulo V. Campregher, Nelson Hamerschlak, Lucila N. Kerbauy
Read the full article here.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement